The pathogenic mechanism involves chemerin acting as a pro-inflammatory cytokine, which promotes insulin resistance, a key feature of GDM, by disrupting glucose uptake, influencing pancreatic beta-cell function, and correlating with other inflammatory markers associated with GDM [82]. This evidence concerns the gene RARRES2 and gestational diabetes.